Metrodora Therapeutics is dedicated to treating inflammation, infection and microbiome dysregulation. Our specialty focus thereby includes a commitment to serving the health and medical needs of people throughout their lives, and particularly so during vulnerable stages such as pregnancy, preterm birth and old age. Because the well-being of our patients is the core element of our mission, we consciously and routinely foster a patient-centric culture. Our culture is biased toward action, with an unbending commitment to service and excellence through innovation.
View Top Employees from Metrodora Therapeutics, Inc.Website | http://www.metrodora.com |
Revenue | $4 million |
Employees | 2 (2 on RocketReach) |
Address | 1100 Dexter Ave N Ste 100, Seattle, Washington 98109, US |
Phone | (206) 607-8976 |
Technologies |
JavaScript,
HTML,
GoDaddy DNS
+6 more
(view full list)
|
Industry | Biotechnology, Business Services General, Maternal Fetal Medicine, Business Services, Women's Health, Pregnancy |
Competitors | Madison Avenue OB/GYN, ROCKY MOUNTAIN WOMEN'S HEALTH CENTER, INC., Sera Prognostics |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies |
Looking for a particular Metrodora Therapeutics, Inc. employee's phone or email?
The Metrodora Therapeutics, Inc. annual revenue was $4 million in 2024.
Maura Matthews is the Vice President, Drug Development of Metrodora Therapeutics, Inc..
2 people are employed at Metrodora Therapeutics, Inc..
Metrodora Therapeutics, Inc. is based in Seattle, Washington.
The NAICS codes for Metrodora Therapeutics, Inc. are [54, 54171, 541, 541711, 5417].
The SIC codes for Metrodora Therapeutics, Inc. are [87, 873].